Search Results - "Lin, Jasper C"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    A pre-existing hydrophobic collapse in the unfolded state of an ultrafast folding protein by HUN MOK, K, KUHN, Lars T, GOEZ, Martin, DAY, Iain J, LIN, Jasper C, ANDERSEN, Niels H, HORE, P. J

    Published in Nature (03-05-2007)
    “…Insights into the conformational passage of a polypeptide chain across its free energy landscape have come from the judicious combination of experimental…”
    Get full text
    Journal Article
  2. 2

    High-resolution mapping of epitopes on the C2 domain of factor VIII by analysis of point mutants using surface plasmon resonance by Nguyen, Phuong-Cac T., Lewis, Kenneth B., Ettinger, Ruth A., Schuman, Jason T., Lin, Jasper C., Healey, John F., Meeks, Shannon L., Lollar, Pete, Pratt, Kathleen P.

    Published in Blood (24-04-2014)
    “…Neutralizing anti-factor VIII (FVIII) antibodies that develop in patients with hemophilia A and in murine hemophilia A models, clinically termed “inhibitors,”…”
    Get full text
    Journal Article
  3. 3

    Crystal and NMR structures of a Trp-cage mini-protein benchmark for computational fold prediction by Scian, Michele, Lin, Jasper C, Le Trong, Isolde, Makhatadze, George I, Stenkamp, Ronald E, Andersen, Niels H

    “…To provide high-resolution X-ray crystallographic structures of a peptide with the Trp-cage fold, we prepared a cyclized version of this motif. Cyclized…”
    Get full text
    Journal Article
  4. 4

    Six amino acid residues in a 1200 Å2 interface mediate binding of factor VIII to an IgG4κ inhibitory antibody by Lin, Jasper C, Ettinger, Ruth A, Schuman, Jason T, Zhang, Ai-Hong, Wamiq-Adhami, Muhammad, Nguyen, Phuong-Cac T, Nakaya-Fletcher, Shelley M, Puranik, Komal, Thompson, Arthur R, Pratt, Kathleen P

    Published in PloS one (2015)
    “…The development of neutralizing anti-factor VIII (FVIII) antibodies complicates the treatment of many hemophilia A patients. The C-terminal C2 domain is a…”
    Get full text
    Journal Article
  5. 5

    Assessing the Utility of Circular Dichroism and FTIR Spectroscopy in Monoclonal-Antibody Comparability Studies by Lin, Jasper C, Glover, Zephania Kwong, Sreedhara, Alavattam

    Published in Journal of pharmaceutical sciences (01-12-2015)
    “…Protein characterization is a necessary activity during development, technical transfers, and licensure. One important aspect of protein characterization is…”
    Get more information
    Journal Article
  6. 6

    Best Practices for Aggregate Quantitation of Antibody Therapeutics by Sedimentation Velocity Analytical Ultracentrifugation by Bou-Assaf, George M, Budyak, Ivan L, Brenowitz, Michael, Day, Eric S, Hayes, David, Hill, John, Majumdar, Ranajoy, Ringhieri, Paola, Schuck, Peter, Lin, Jasper C

    Published in Journal of pharmaceutical sciences (01-07-2022)
    “…Analytical ultracentrifugation (AUC) is a critical analytical tool supporting the development and manufacture of protein therapeutics. AUC is routinely used as…”
    Get more information
    Journal Article
  7. 7

    Measurement and Characterization of Hydrogen–Deuterium Exchange Chemistry Using Relaxation Dispersion NMR Spectroscopy by Khirich, Gennady, Holliday, Michael J, Lin, Jasper C, Nandy, Aditya

    Published in The journal of physical chemistry. B (01-03-2018)
    “…One-dimensional heteronuclear relaxation dispersion NMR spectroscopy at 13C natural abundance successfully characterized the dynamics of the hydrogen–deuterium…”
    Get full text
    Journal Article
  8. 8

    The Trp-cage: optimizing the stability of a globular miniprotein by Barua, Bipasha, Lin, Jasper C., Williams, Victoria D., Kummler, Phillip, Neidigh, Jonathan W., Andersen, Niels H.

    Published in Protein engineering, design and selection (01-03-2008)
    “…The Trp-cage, as the smallest miniprotein, remains the subject of numerous computational and experimental studies of protein folding dynamics and pathways. The…”
    Get full text
    Journal Article
  9. 9

    The Helical Alanine Controversy:  An (Ala)6 Insertion Dramatically Increases Helicity by Lin, Jasper C, Barua, Bipasha, Andersen, Niels H

    Published in Journal of the American Chemical Society (27-10-2004)
    “…Employing chemical shift melts and hydrogen/deuterium exchange NMR techniques, we have determined the stabilization of the Trp-cage miniprotein due to multiple…”
    Get full text
    Journal Article
  10. 10

    Lysine and arginine residues do not increase the helicity of alanine-rich peptide helices by Stewart, James M, Lin, Jasper C, Andersen, Niels H

    “…The helix-disfavoring, versus alanine, propagation values of lysine (0.8) and arginine (1.0) residues placed centrally in an (Ala)(9) unit have been measured…”
    Get more information
    Journal Article
  11. 11
  12. 12

    B-Cell Epitope Mapping of Monoclonal Anti-Factor VIII C2 Domain Inhibitors: Identification of Amino Acids That Contribute Significant Antigen-Antibody Binding Affinity by Lin, Jasper C., Schuman, Jason T., Meeks, Shannon L., Healey, John F., Thompson, Arthur R., Pratt, Kathleen P.

    Published in Blood (16-11-2008)
    “…The most troublesome clinical complication that can afflict hemophilia A patients who receive factor VIII (FVIII) infusions as replacement therapy is the…”
    Get full text
    Journal Article
  13. 13

    Six Amino Acid Residues in a 1200 Å2 Interface Mediate Binding of Factor VIII to An IgG4 Inhibitory Antibody by Lin, Jasper C., Schuman, Jason T., Nakaya, Shelley M., Kaushik, Vasudha, Jacquemin, Marc, Thompson, Arthur R., Pratt, Kathleen P.

    Published in Blood (16-11-2008)
    “…Approximately one quarter of severe hemophilia A patients who receive Factor VIII (FVIII) injections develop antibodies, clinically referred to as…”
    Get full text
    Journal Article
  14. 14

    Six Amino Acid Residues in a 1200 Å2 Interface Mediate Binding of Factor VIII to An IgG4 Inhibitory Antibody by Lin, Jasper C., Schuman, Jason T., Nakaya, Shelley M., Kaushik, Vasudha, Jacquemin, Marc, Thompson, Arthur R., Pratt, Kathleen P.

    Published in Blood (16-11-2008)
    “…Abstract Approximately one quarter of severe hemophilia A patients who receive Factor VIII (FVIII) injections develop antibodies, clinically referred to as…”
    Get full text
    Journal Article